Desmopressin Nasal — Membership Pricing

Other medications in Urology

• Doxazosin
• Dutasteride
• Dutasteride/Tamsulosin
• Fesoterodine
• Finasteride
• Mirabegron
• Oxybutynin
• Oxybutynin Topical

About Desmopressin Nasal

Desmopressin nasal is a crucial medication primarily used to manage specific conditions affecting fluid balance and clotting. For those who rely on this prescription, understanding its function and potential costs is vital. TheDrugClub is committed to helping members navigate medication expenses, offering various options to achieve savings on essential prescriptions like desmopressin nasal.

Desmopressin nasal is a synthetic analog of vasopressin, a hormone naturally produced in the body. It plays a significant role in managing several conditions, offering relief and improved quality of life for many patients.

What Desmopressin Nasal Treats

This medication is primarily prescribed for:

• Central Diabetes Insipidus (CDI): A rare condition where the body doesn't produce enough vasopressin, leading to excessive thirst and urination. Desmopressin helps reduce urine output and thirst by mimicking the natural hormone.
• Nocturnal Enuresis (Bedwetting): In certain cases, desmopressin nasal is used to treat primary nocturnal enuresis in children and adults who have normal kidney function and have not responded to other treatments. It works by reducing the amount of urine produced overnight.
• Hemophilia A and von Willebrand Disease (Type 1): Desmopressin can temporarily increase the levels of certain clotting factors (Factor VIII and von Willebrand factor) in the blood, which can be useful for managing bleeding episodes or preventing bleeding during minor procedures in patients with mild forms of these bleeding disorders.

How Desmopressin Nasal Works

Desmopressin works by binding to specific receptors (V2 receptors) in the kidneys. This action signals the kidneys to reabsorb more water back into the bloodstream, thereby concentrating the urine and reducing the total volume of urine produced. For conditions like central diabetes insipidus and nocturnal enuresis, this mechanism helps to control excessive urination. When used for bleeding disorders, desmopressin promotes the release of Factor VIII and von Willebrand factor from storage sites within the body, improving the blood's clotting ability.

Typical Costs of Desmopressin Nasal

The cost of desmopressin nasal can vary significantly based on

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Desmopressin Nasal is approved for (FDA label)

STIMATE is a vasopressin analog used for: Hemophilia A - for patients with factor VIII coagulant activity levels greater than 5% to maintain hemostasis during surgical procedures and postoperatively or reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding. ( 1.1 ) von Willebrand’s disease (Type I) - for patients with mild to moderate disease with factor VIII levels greater than 5% to maintain hemostasis during surgical procedures or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding. ( 1.2 ) Limitations of Use STIMATE is not indicated for: von Willebrand’s disease (severe Type I) - not indicated for the treatment of patients with severe Type I von Willebrand’s disease and when there is evidence of an abnormal molecular form of factor VIII antigen. ( 1.2 ) 1.1 Hemophilia A STIMATE is indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5% without factor VIII antibodies to: Maintain hemostasis during surgical procedures and postoperatively Reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding. 1.2 von Willebrand’s Disease (Type I) STIMATE is indicated for patients with mild to moderate von Willebrand’s disease (Type I) with factor VIII levels greater than 5% to: Maintain hemostasis during surgical procedures and postoperatively Reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, mucosal bleeding, or menorrhagia.

Source: Read the full FDA label on DailyMed. Label effective date: July 22, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Desmopressin Nasal (FDA label)

STIMATE pump delivers 150 mcg (0.1 mL) of desmopressin acetate per spray. STIMATE is available as a 2.5 mL bottle with spray pump delivering 25 sprays. Nasal Spray: 150 mcg per 0.1 mL spray, available in a 2.5 mL bottle with spray pump delivering 25 sprays ( 3 )

Source: FDA prescribing information (DailyMed). Set ID: f5ada39c-20ed-4500-9dce-1e4ab642a358. SPL document ID: 6beb1a83-b970-4d4a-965c-2972718e5916. Label effective date: July 22, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Desmopressin Nasal (FDA label)

The following serious reactions are described below and elsewhere in the labeling: Hyponatremia [see Warnings and Precautions ( 5.1 )]. Hypotension and Hypertension [see Warnings and Precautions ( 5.2 )] . Altered Absorption in Patients with Changes in Nasal Mucosa [see Warnings and Precautions ( 5.3 )] . Hypersensitivity Reactions [see Warnings and Precautions ( 5.4 )] . Increased Risk of Thrombosis in Patients with von Willebrand’s Disease Type IIB [see Warnings and Precautions ( 5.5 )] . The following adverse reactions have been identified during post-approval use of desmopressin acetate intranasal formulations.

Source: FDA prescribing information (DailyMed). Set ID: f5ada39c-20ed-4500-9dce-1e4ab642a358. SPL document ID: 6beb1a83-b970-4d4a-965c-2972718e5916. Label effective date: July 22, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Desmopressin Nasal (FDA label)

STIMATE is contraindicated in patients with: Known hypersensitivity to desmopressin acetate or to any of the components of STIMATE. Severe allergic reactions and anaphylaxis have been reported [see Warnings and Precautions ( 5.4 )]. Hyponatremia or a history of hyponatremia [see Warnings and Precautions ( 5.1 )] . Type IIB von Willebrand's disease [see Warnings and Precautions ( 5.5 ) Known or suspected syndrome of inappropriate antidiuretic hormone (SIADH) secretion [see Warnings and Precautions ( 5.1 )] . Known hypersensitivity to desmopressin acetate or to any of the components of STIMATE ( 4 , 5.4 ) Hyponatremia or a history of hyponatremia ( 4 , 5.1 ) Type IIB von Willebrand's disease ( 4 , 5.5 ) Known or suspected syndrome of inappropriate antidiuretic hormone (SIADH) secretion. ( 4 )

Source: FDA prescribing information (DailyMed). Set ID: f5ada39c-20ed-4500-9dce-1e4ab642a358. SPL document ID: 6beb1a83-b970-4d4a-965c-2972718e5916. Label effective date: July 22, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Desmopressin Nasal (FDA label)

Hyponatremia : Excessive fluid intake when urine output is limited by the antidiuretic effect of desmopressin may lead to water intoxication with hyponatremia. ( 5.1 ) Hypotension and Hypertension : May cause hypotension with compensatory increase in heart rate or hypertension. Monitor blood pressure during STIMATE administration, especially in patients with heart disease. ( 5.2 ) Altered Absorption in Patients with Nasal Mucosa Abnormalities: changes in the nasal mucosa such as scarring, edema, or other disease may cause erratic, unreliable absorption. ( 5.3 ) Hypersensitivity Reactions : Severe reactions have occurred. Monitor for reactions during administration and interrupt if reaction occurs. ( 5.4 ) Increased Risk of Thrombosis in Patients with von Willebrand’s Disease Type IIB : Use of STIMATE in patients with Type IIB von Willebrand’s disease may cause thrombosis due to platelet aggregation. ( 5.5 ) 5.1 Hyponatremia Serious and fatal hyponatremia may occur with STIMATE use.

Source: FDA prescribing information (DailyMed). Set ID: f5ada39c-20ed-4500-9dce-1e4ab642a358. SPL document ID: 6beb1a83-b970-4d4a-965c-2972718e5916. Label effective date: July 22, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Desmopressin Nasal (FDA label)

Other Drugs that may Increase Risk of Hyponatremia: Monitor serum sodium more frequently. ( 7.1 ) Other Vasoconstrictors: May require a reduction of the STIMATE dosage. ( 7.2 ) 7.1 Other Drugs that may Increase Risk of Hyponatremia The concomitant administration of STIMATE with other drugs that may increase the risk of water intoxication with hyponatremia, (e.g., tricyclic antidepressants, selective serotonin re-uptake inhibitors, chlorpromazine, opiate analgesics, NSAIDs, lamotrigine, and carbamazepine) requires more frequent serum sodium monitoring [see Warnings and Precautions ( 5.1 ) and Adverse Reactions ( 6 )] . 7.2 Other Vasoconstrictors Desmopressin acetate can elevate blood pressure. Use of large doses of STIMATE with other vasoconstrictors may require a reduction of the STIMATE dosage [ see Warnings and Precautions ( 5.2 ) ] .

Source: FDA prescribing information (DailyMed). Set ID: f5ada39c-20ed-4500-9dce-1e4ab642a358. SPL document ID: 6beb1a83-b970-4d4a-965c-2972718e5916. Label effective date: July 22, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.